Global Medical REIT, Inc Stock News

Global Medical REIT Inc. (NYSE:GMRE ) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Company Participants Steve Swett - Investor Relations Jeff Busch - Chief Executive Officer Alfonzo Leon -

Many REITs are today very opportunistic. But not all of them are.

On March this year, I reiterated my buy rating for GMRE that was initially issued back at the beginning of 2019. The key drivers of my bull thesis were resilient cash flow generation, well-structured

Three Small Cap REITs That Can't Be Beat.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires healthcare facilit

Billionaire Barry Sternlicht is buying REITs. He explains that there are "unbelievable bargains" in REITs.

Global Medical REIT is a fast-growing healthcare REIT. The dividend is covered by FFO and the trust is raising its pay-out.

Not all REITs have a low dividend yield. Some yield as much as 10%.

REIT dividend yields are high today. This suggests that their dividends may be at risk.

Investors need to pay close attention to Global Medical REIT (GMRE) stock based on the movements in the options market lately.

Since the start of 2022, Global Medical REIT has lost all of its relative gains achieved in the previous years compared to the broader REIT indices. Currently, GMRE offers close to a 10% dividend yiel

In general, investors who park their capital in dividend stocks tend to be more conservative with their money. They tend to like the dependable dividends paid from their stock holdings, often used a

I'm beginning to see more and more readers on Seeking Alpha chasing yield. That's not necessarily a bad thing, especially if you do your homework and research before you buy.

For Healthcare REITs - the physical epicenter of the pandemic - the road to recovery has remained inconsistent across its distinct sub-sectors, with "private-pay" segments now showing notable improvem

Global Medical REIT beat estimates for Q4-2022. They have managed their interest rate risk rather well and management is focused on value creation.